Coronary artery dissection in adult-onset homocystinuria

Brigitte Granel1, Pascal Rossi, Laurent Bonello

  • 1Hopital Nord, Internal Medicine, Chemin des Bourrely, Marseille, 13915, France.

BMJ Case Reports
|September 3, 2011
PubMed

Insights

This case report details the first instance of spontaneous arterial coronary dissection in adult-onset homocystinuria, leading to myocardial infarction. Early diagnosis and pyridoxine treatment normalized homocysteine levels.

Area of Science:

  • Cardiology
  • Genetics
  • Metabolic Disorders

Background:

  • Homocystinuria is a rare metabolic disorder associated with an increased risk of thrombotic events.
  • Spontaneous coronary artery dissection (SCAD) is an uncommon cause of myocardial infarction, particularly in adults.
  • Delayed diagnosis of homocystinuria can lead to severe cardiovascular complications.

Purpose of the Study:

  • To report the first case of SCAD in adult-onset homocystinuria.
  • To highlight the diagnostic challenges and clinical manifestations of homocystinuria.
  • To emphasize the importance of early diagnosis and management of homocystinuria for preventing cardiovascular events.

Main Methods:

  • Case presentation of a patient with adult-onset homocystinuria.
  • Review of patient's medical history including thrombotic events and clinical findings.
  • Genetic analysis of the Cystathionine β-synthase (CBS) gene.
  • Biochemical assessment of plasma homocysteine levels before and after treatment.

Main Results:

  • The patient experienced spontaneous arterial coronary dissection leading to premature myocardial infarction.
  • A history of unexplained venous and arterial thrombosis was noted, with diagnosis of homocystinuria delayed by 20 years.
  • Pectus carinatum was the sole identified clinical feature related to homocystinuria phenotype.
  • Compound heterozygous mutations in the CBS gene were identified.
  • Plasma homocysteine levels normalized after 3 months of pyridoxine treatment.

Conclusions:

  • Adult-onset homocystinuria can present with severe cardiovascular complications such as SCAD and myocardial infarction.
  • Early detection and management of homocystinuria are crucial to prevent thrombotic events.
  • Pyridoxine is an effective treatment for normalizing homocysteine levels in patients with CBS gene mutations.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...